Cervical excisional treatment of young women: A population-based study Walter Kinney, William C. Hunt, Helen Dinkelspiel, Michael Robertson, Jack Cuzick, Cosette M. Wheeler  Gynecologic Oncology  Volume 132, Issue 3, Pages 628-635 (March 2014) DOI: 10.1016/j.ygyno.2013.12.037 Copyright © 2013 The Authors Terms and Conditions

Fig. 1 Percent of women with colposcopic biopsy or endocervical curettage (ECC) within 12months of abnormal index screening cytology by age of woman and result of cytology. Cytology results are classified as ASC-US [atypical squamous cells of undetermined significance, negative for high-risk human papillomavirus (HPV) or HPV status unknown], ASC-US+ [ASC-US, positive for high-risk HPV], LSIL [low-grade squamous intraepithelial lesion], ASC-H [atypical squamous cells-cannot rule out high-grade], and HSIL [high-grade squamous intraepithelial lesion]. Gynecologic Oncology 2014 132, 628-635DOI: (10.1016/j.ygyno.2013.12.037) Copyright © 2013 The Authors Terms and Conditions

Fig. 2 (A). Percent of women with colposcopic biopsy or endocervical curettage (ECC) within 12month of index screening cytology with result of ASC-US+ [atypical squamous cells of unknown significance, high-risk human papillomavirus (HPV) positive] or more severe by age of woman and year of cytology. (B). Percent of women receiving excisional treatment (LEEP) following colposcopic biopsy or endocervical curettage (ECC) with diagnosis of negative, cervical intraepithelial neoplasia grade 1 (CIN1), or cervical intraepithelial neoplasia grade 2 (CIN2) accompanied by less than high-grade squamous intraepithelial lesion (<HSIL) cytology. (C). Percent of excisional treatment (LEEP) with diagnosis of CIN3+ [CIN grade 3 or worse] by age of women and year of biopsy. Gynecologic Oncology 2014 132, 628-635DOI: (10.1016/j.ygyno.2013.12.037) Copyright © 2013 The Authors Terms and Conditions